Coronary Stent Market – Hospitals form the fastest growing end user segment
The coronary stent market
is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in
2016, at a CAGR of 7.6% from 2016 to 2021. The market is mainly driven
by factors such as technological advancements, increasing number of
percutaneous coronary intervention (PCI) procedures, rising burden of
CAD, increasing demand for minimally invasive procedures, and rising
geriatric population.
A coronary stent is a small, expandable tube-shaped
device placed in the coronary arteries that supply blood to the heart.
Coronary stents are used in percutaneous coronary intervention (PCI)
procedures to treat patients with coronary artery disease (CAD). They
are used for a wide range of indications in CAD, including de novo
lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous
and narrow lesions.
Hospitals
This segment includes both government and private
hospitals that provide treatment to the patients with CAD. The market
for this segment is mainly driven by the rising patient pool, growing
number of PCI procedures in hospitals, improving healthcare
infrastructure, and favorable reimbursement scenario in developed and
developing countries. In addition, major players in the coronary stents
market are adopting various strategies to enhance the utilization of
stents in hospitals.
Comments
Post a Comment